Dolutegravir and neuropsychiatric adverse events: a continuing debate.
Sign Up to like & getrecommendations! Published in 2017 at "AIDS"
DOI: 10.1097/qad.0000000000001596
Abstract: We read with great interest the series of letters regarding dolutegravir-related neuropsychiatric adverse events (NP-AE) [1–4]. We report, here, our experience in a French cohort, to add on the current debate. Data were obtained from… read more here.
Keywords: adverse events; continuing debate; events continuing; neuropsychiatric adverse ... See more keywords